vs
Natera, Inc.（NTRA）与Rollins, Inc.（ROL）财务数据对比。点击上方公司名可切换其他公司
Rollins, Inc.的季度营收约是Natera, Inc.的1.4倍（$906.4M vs $665.5M），Rollins, Inc.净利率更高（11.9% vs 7.1%，领先4.8%），Natera, Inc.同比增速更快（39.8% vs 10.2%），Rollins, Inc.自由现金流更多（$111.2M vs $37.8M），过去两年Natera, Inc.的营收复合增速更高（34.5% vs 0.8%）
Natera是总部位于美国得克萨斯州奥斯汀的临床基因检测企业，主打无创游离DNA（cfDNA）检测技术，业务覆盖女性健康、肿瘤及器官健康三大核心赛道。其自研专利技术结合前沿分子生物学手段与生物信息学工具矩阵，可实现单管血液样本中低至单个分子级别的高灵敏度检测。
Rollins, Inc.是北美知名虫害防治服务商，面向住宅及商业客户提供专业防控服务。公司依托Orkin、HomeTeam Pest Defense等多家全资子公司布局全球业务，覆盖北美、英国等市场，在民用及商用虫害治理领域具备深厚的行业积累与品牌优势。
NTRA vs ROL — 直观对比
营收规模更大
ROL
是对方的1.4倍
$665.5M
营收增速更快
NTRA
高出29.6%
10.2%
净利率更高
ROL
高出4.8%
7.1%
自由现金流更多
ROL
多$73.4M
$37.8M
两年增速更快
NTRA
近两年复合增速
0.8%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $665.5M | $906.4M |
| 净利润 | $47.3M | $107.8M |
| 毛利率 | — | — |
| 营业利润率 | -3.4% | 16.1% |
| 净利率 | 7.1% | 11.9% |
| 营收同比 | 39.8% | 10.2% |
| 净利润同比 | 187.9% | 2.5% |
| 每股收益（稀释后） | $0.36 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NTRAROL
| Q1 26 | — | $906.4M | ||
| Q4 25 | $665.5M | $912.9M | ||
| Q3 25 | $592.2M | $1.0B | ||
| Q2 25 | $546.6M | $999.5M | ||
| Q1 25 | $501.8M | $822.5M | ||
| Q4 24 | $476.1M | $832.2M | ||
| Q3 24 | $439.8M | $916.3M | ||
| Q2 24 | $413.4M | $891.9M |
净利润NTRAROL
| Q1 26 | — | $107.8M | ||
| Q4 25 | $47.3M | $116.4M | ||
| Q3 25 | $-87.5M | $163.5M | ||
| Q2 25 | $-100.9M | $141.5M | ||
| Q1 25 | $-66.9M | $105.2M | ||
| Q4 24 | $-53.8M | $105.7M | ||
| Q3 24 | $-31.6M | $136.9M | ||
| Q2 24 | $-37.5M | $129.4M |
营业利润率NTRAROL
| Q1 26 | — | 16.1% | ||
| Q4 25 | -3.4% | 17.5% | ||
| Q3 25 | -16.5% | 21.9% | ||
| Q2 25 | -20.2% | 19.8% | ||
| Q1 25 | -15.8% | 17.3% | ||
| Q4 24 | -13.6% | 18.1% | ||
| Q3 24 | -8.9% | 20.9% | ||
| Q2 24 | -10.6% | 20.4% |
净利率NTRAROL
| Q1 26 | — | 11.9% | ||
| Q4 25 | 7.1% | 12.8% | ||
| Q3 25 | -14.8% | 15.9% | ||
| Q2 25 | -18.5% | 14.2% | ||
| Q1 25 | -13.3% | 12.8% | ||
| Q4 24 | -11.3% | 12.7% | ||
| Q3 24 | -7.2% | 14.9% | ||
| Q2 24 | -9.1% | 14.5% |
每股收益（稀释后）NTRAROL
| Q1 26 | — | $0.22 | ||
| Q4 25 | $0.36 | $0.24 | ||
| Q3 25 | $-0.64 | $0.34 | ||
| Q2 25 | $-0.74 | $0.29 | ||
| Q1 25 | $-0.50 | $0.22 | ||
| Q4 24 | $-0.41 | $0.22 | ||
| Q3 24 | $-0.26 | $0.28 | ||
| Q2 24 | $-0.30 | $0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $116.5M |
| 总债务越低越好 | — | $650.6M |
| 股东权益账面价值 | $1.7B | $1.4B |
| 总资产 | $2.4B | $3.2B |
| 负债/权益比越低杠杆越低 | — | 0.47× |
8季度趋势，按日历期对齐
现金及短期投资NTRAROL
| Q1 26 | — | $116.5M | ||
| Q4 25 | — | $100.0M | ||
| Q3 25 | $1.0M | $127.4M | ||
| Q2 25 | $16.0M | $123.0M | ||
| Q1 25 | $17.8M | $201.2M | ||
| Q4 24 | $22.7M | $89.6M | ||
| Q3 24 | $29.5M | $95.3M | ||
| Q2 24 | $90.3M | $106.7M |
总债务NTRAROL
| Q1 26 | — | $650.6M | ||
| Q4 25 | — | $486.1M | ||
| Q3 25 | — | $485.7M | ||
| Q2 25 | — | $485.3M | ||
| Q1 25 | — | $485.5M | ||
| Q4 24 | — | $395.3M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益NTRAROL
| Q1 26 | — | $1.4B | ||
| Q4 25 | $1.7B | $1.4B | ||
| Q3 25 | $1.3B | $1.5B | ||
| Q2 25 | $1.2B | $1.4B | ||
| Q1 25 | $1.2B | $1.4B | ||
| Q4 24 | $1.2B | $1.3B | ||
| Q3 24 | $878.5M | $1.3B | ||
| Q2 24 | $836.5M | $1.2B |
总资产NTRAROL
| Q1 26 | — | $3.2B | ||
| Q4 25 | $2.4B | $3.1B | ||
| Q3 25 | $1.8B | $3.2B | ||
| Q2 25 | $1.8B | $3.2B | ||
| Q1 25 | $1.7B | $2.9B | ||
| Q4 24 | $1.7B | $2.8B | ||
| Q3 24 | $1.6B | $2.8B | ||
| Q2 24 | $1.5B | $2.8B |
负债/权益比NTRAROL
| Q1 26 | — | 0.47× | ||
| Q4 25 | — | 0.35× | ||
| Q3 25 | — | 0.32× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.36× | ||
| Q4 24 | — | 0.30× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $73.9M | $118.4M |
| 自由现金流经营现金流 - 资本支出 | $37.8M | $111.2M |
| 自由现金流率自由现金流/营收 | 5.7% | 12.3% |
| 资本支出强度资本支出/营收 | 5.4% | 0.8% |
| 现金转化率经营现金流/净利润 | 1.56× | 1.10× |
| 过去12个月自由现金流最近4个季度 | $109.1M | $621.1M |
8季度趋势，按日历期对齐
经营现金流NTRAROL
| Q1 26 | — | $118.4M | ||
| Q4 25 | $73.9M | $164.7M | ||
| Q3 25 | $59.4M | $191.3M | ||
| Q2 25 | $37.6M | $175.1M | ||
| Q1 25 | $44.5M | $146.9M | ||
| Q4 24 | $52.9M | $188.2M | ||
| Q3 24 | $51.8M | $146.9M | ||
| Q2 24 | $4.0M | $145.1M |
自由现金流NTRAROL
| Q1 26 | — | $111.2M | ||
| Q4 25 | $37.8M | $159.0M | ||
| Q3 25 | $37.0M | $182.8M | ||
| Q2 25 | $11.7M | $168.0M | ||
| Q1 25 | $22.6M | $140.1M | ||
| Q4 24 | $34.8M | $184.0M | ||
| Q3 24 | $35.5M | $139.4M | ||
| Q2 24 | $-7.7M | $136.4M |
自由现金流率NTRAROL
| Q1 26 | — | 12.3% | ||
| Q4 25 | 5.7% | 17.4% | ||
| Q3 25 | 6.2% | 17.8% | ||
| Q2 25 | 2.1% | 16.8% | ||
| Q1 25 | 4.5% | 17.0% | ||
| Q4 24 | 7.3% | 22.1% | ||
| Q3 24 | 8.1% | 15.2% | ||
| Q2 24 | -1.9% | 15.3% |
资本支出强度NTRAROL
| Q1 26 | — | 0.8% | ||
| Q4 25 | 5.4% | 0.6% | ||
| Q3 25 | 3.8% | 0.8% | ||
| Q2 25 | 4.7% | 0.7% | ||
| Q1 25 | 4.3% | 0.8% | ||
| Q4 24 | 3.8% | 0.5% | ||
| Q3 24 | 3.7% | 0.8% | ||
| Q2 24 | 2.8% | 1.0% |
现金转化率NTRAROL
| Q1 26 | — | 1.10× | ||
| Q4 25 | 1.56× | 1.41× | ||
| Q3 25 | — | 1.17× | ||
| Q2 25 | — | 1.24× | ||
| Q1 25 | — | 1.40× | ||
| Q4 24 | — | 1.78× | ||
| Q3 24 | — | 1.07× | ||
| Q2 24 | — | 1.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
